Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)
Clinical trial NCT03293485 · COMPLETED
Trial details
- NCT number
- NCT03293485
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-04
- Primary completion
- 2018-09-14
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.